Saturday, 22 June 2024

Australia's most trusted
source of pharma news

Saturday, 22 June 2024
Listen to this story 

Aussie industry's $2M-dollar- man

Posted 7 June 2024 PM

Sigma is clearly intent on keeping its CEO on board and news that shareholders had agreed to pay Vivek Ramsunder a handsome retention bonus worth up to $2 million was our top story this week.

Under the deal Ramsunder is eligible for a payment of $1 million in December this year. A second retention payment of $500,000 is scheduled for 12 months later but if the company's proposed merger with Chemist Warehouse falls over, the deal becomes even sweeter with the second payment to increase to $1 million. With such a big sum, however, not everyone was happy and the vote went down to the wire. Find out just how close it was in: Aussie boss paid up to $2M to stay

To see the whole article, please login

Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (29)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (7)

Other (20)

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.